Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Population-based incidence rates and increased risk of EGFR mutated non-small cell lung cancer in Māori and Pacifica in New Zealand.

PloS one - 1 Jan 2021

Aye Phyu Sin, McKeage Mark James, Tin Tin Sandar, Khwaounjoo Prashannata, Elwood J Mark

Abstract excerpt

BACKGROUND: Non-squamous non-small cell lung cancer (NSCLC) patients with Epidermal Growth Factor Receptor (EGFR) mutation benefit from targeted treatments. Previous studies reported EGFR mutation-positive proportions among tested non-squamous NSCLC patients. However, incidence rates and population risk of EGFR mutation-positive and EGFR mutation-negative non-squamous NSCLC have not been assessed. This study...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adolescent
Share to Aged, 80 and over

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Carcinoma, Non-Small-Cell Lung

Share to ErbB Receptors

Share to Incidence

Share to Lung Neoplasms

Share to New Zealand

Share to Young Adult

Source

Open in PubMed Open full text

Identifiers

PMID: 33961689
DOI: 10.1371/journal.pone.0251357
PMCID: PMC8104366

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Population-based incidence rates and increased risk of EGFR mutated non-small cell lung cancer in Māori and Pacifica in New Zealand.PMID 33961689Read ↗

Factors associated with overall survival in patients with non-squamous NSCLC in New Zealand: A comparative analysis by EGFR gene mutation statusSemantic proximity Read ↗

Factors associated with overall survival in a population-based cohort of non- squamous NSCLC patients from northern New Zealand: A comparative analysis by EGFR mutation status.Semantic proximity Read ↗

Development and validation of a predictive model for estimating EGFR mutation probabilities in patients with non-squamous non-small cell lung cancer in New Zealand.Semantic proximity Read ↗

Identifying lung cancer patients who may be eligible for epidermal growth factor receptor (EGFR) mutation testing.Semantic proximity Read ↗

Prevalence and Patterns of EGFR Mutations in Non-Small Cell Lung Cancer in the Middle East and North Africa: A Systematic ReviewSemantic proximity Read ↗

The prevalence of EGFR mutation in patients with non-small cell lung cancer: a systematic review and meta-analysis.Semantic proximity Read ↗

Diagnostic work-up and systemic treatment for advanced non-squamous non-small-cell lung cancer in four Southeast Asian countries.Semantic proximity Read ↗

Molecular patterns of egyptian patients with non-squamous non-small-cell lung cancers: a clinicopathological study.Semantic proximity Read ↗

EGFR Mutation in Non-squamous Non-small-cell Lung Carcinoma (NS-NSCLC) in the Arab World: A systematic Review.Semantic proximity Read ↗

The prevalence and clinical significance of EGFR mutations in non-small cell lung cancer patients in Egypt: a screening study.Semantic proximity Read ↗

EGFR-mutation testing, treatment patterns and clinical outcomes in patients with stage IB-IIIA non-small cell lung cancer in Norway-a nationwide cohort study.Semantic proximity Read ↗

Clinical outcomes in patients with advanced epidermal growth factor receptor-mutated non-small-cell lung cancer in South Western Sydney Local Health District.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.